Wikidata:Database reports/Constraint violations/P3780

• Summary
• List of properties
• Property proposal
• Popular properties
• Special:ConstraintReport

Constraint violations report for active ingredient in (Discussion, uses, items, changes, related properties): is part of and forms biologically active component. Inverse of "has active ingredient"
Data time stamp: 22 November 2024, 11:11 (UTC) — Items processed: 1,398
The report is generated based on the settings on Property:P3780#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
• inverse property: has active ingredient → Wikidata:Database reports/Constraint violations/P3781#Inverse

"Self link" violations

Violations count: 2

• clarithromycin (Q118551)
• buprenorphine/naloxone (Q25048068)

"Inverse" violations

Violations count: 47

• ethanol (Q153): rectified spirit (Q266143)
• calcium carbonate (Q23767): Calcichew (Q2514011)
• clarithromycin (Q118551): clarithromycin (Q118551)
• 4-hydroxybutyric acid (Q207920): Xyrem (Q29006703)
• entecavir (Q418586): Baraclude (Q29004884)
• dabigatran (Q419345): Pradaxa (Q29006351)
• fondaparinux sodium (Q421218): Arixtra (Q29004851)
• azilsartan medoxomil (Q1087888): Edarbi (Q29005764)
• samarium sm-153 lexidronam pentasodium (Q3470652): Quadramet (Q29006386)
• canagliflozin (Q5030940): Invokana (Q29006019)
• fluocinonide (Q5462791): VANOS (Q2297093)
• isavuconazole (Q6079042): Cresemba (Q29005676)
• umeclidinium bromide (Q15624035): Incruse (Q29005982)
• tedizolid phosphate (Q21011227): Sivextro (Q29006490)
• human fibrinogen (Q22075876): fibrin glue (Q1410780)
• buprenorphine/naloxone (Q25048068): buprenorphine/naloxone (Q25048068)
• pegaptanib (Q27088289): Macugen (Q29006157)
• cysteamine bitartrate (Q27122045): Cystagon (Q29005688)
• cysteamine bitartrate (Q27122045): Procysbi (Q29006373)
• raloxifene hydrochloride (Q27122215): Evista (Q29005830)
• brimonidine tartrate (Q27122452): Mirvaso (Q29006180)
• fingolimod hydrochloride (Q27132395): Gilenya (Q29005901)
• tenofovir disoproxil fumarate (Q27132754): Viread (Q29006657)
• rilpivirine hydrochloride (Q27137040): Edurant (Q29005767)
• bedaquiline fumarate (Q27139886): Sirturo (Q29006489)
• oritavancin diphosphate (Q27156742): Orbactiv (Q29006288)
• vorapaxar sulfate (Q27156749): Zontivity (Q29006755)
• (3aS)-palonosetron hydrochloride (Q27158366): Aloxi (Q29004410)
• panobinostat DL-lactate (Q27158837): Farydak (Q29005856)
• lenvatinib mesylate (Q27158839): Lenvima (Q29006121)
• cobimetinib fumarate (Q27162831): Cotellic (Q29005672)
• sonidegib phosphate (Q27162838): Odomzo (Q29006249)
• ixazomib citrate (Q27162929): Ninlaro (Q29006222)
• osimertinib mesylate (Q27162942): Tagrisso (Q29006526)
• fentanyl hydrochloride (Q27261701): Ionsys (Q29006021)
• etelcalcetide hydrochloride (Q27266087): Parsabiv (Q29006315)
• fesoterodine fumarate (Q27277274): Toviaz (Q29006585)
• pioglitazone hydrochloride (Q27281642): Actos (Q29004374)
• guanfacine hydrochloride (Q27286641): Intuniv (Q29006012)
• aminolevulinic acid hydrochloride (Q27291473): Ameluz (Q29004417)
• safinamide mesylate (Q27294690): Xadago (Q29006677)
• (−)-nicotine (Q28086552): tobacco product (Q44106)
• sevelamer carbonate (Q28856450): Renvela (Q29006419)
• alcohol (Q47146337): alcoholic beverage (Q154)
• Asparaginase (Q105296036): Spectrila (Q29006500)
• talc (Q108584660): Sclerosol (Q47522115)
• Q129712337: kavalactone (Q408171)

"Scope" violations

Violations count: 23

• Building 18010-10/11 (Q105721629): part of (P361): ceiling (Q221706)
• Building 18010-10/11 (Q105721629): part of (P361): building (Q41176)
• Building 18010-10/11 (Q105721629): part of (P361): entrance (Q1137365)
• Building 18010-10/11 (Q105721629): part of (P361): stairs (Q12511)
• Building 18010-10/11 (Q105721629): part of (P361): flat roof (Q149292)
• Building 18011-223 (Q105721998): part of (P361): entrance (Q1137365)
• Building 18011-223 (Q105721998): part of (P361): yard (Q1623285)
• Building 18011-223 (Q105721998): part of (P361): stairs (Q12511)
• Building 18011-223 (Q105721998): part of (P361): ceiling (Q221706)
• Building 18011-223 (Q105721998): part of (P361): façade (Q183061)
• Building 18011-223 (Q105721998): part of (P361): door (Q36794)
• Building 18011-223 (Q105721998): part of (P361): window (Q35473)
• Building 18011-223 (Q105721998): part of (P361): flower box (Q1042902)
• Building 18013/168 (Q105714876): has part(s) (P527): ceiling (Q221706)
• Building 18013/168 (Q105714876): has part(s) (P527): art museum (Q207694)
• Building 18013/168 (Q105714876): has part(s) (P527): entrance (Q1137365)
• Building 18013/168 (Q105714876): has part(s) (P527): stairs (Q12511)
• Building 18013/168 (Q105714876): has part(s) (P527): flat roof (Q149292)
• Building 18013/168 (Q105714876): has part(s) (P527): concrete (Q22657)
• Building 18013/168 (Q105714876): has part(s) (P527): balcony (Q170552)
• Building 18013/168 (Q105714876): has part(s) (P527): door (Q36794)
• Building 18013/168 (Q105714876): has part(s) (P527): window (Q35473)
• Building 18013/168 (Q105714876): has part(s) (P527): façade (Q183061)